Yingwen Dong Selected Research

Dexpramipexole

12/2014	Pharmacokinetics of renally excreted drug dexpramipexole in subjects with impaired renal function.
11/2013	Dexpramipexole versus placebo for patients with amyotrophic lateral sclerosis (EMPOWER): a randomised, double-blind, phase 3 trial.
1/2013	Dexpramipexole effects on functional decline and survival in subjects with amyotrophic lateral sclerosis in a Phase II study: subgroup analysis of demographic and clinical characteristics.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yingwen Dong Research Topics

Disease

2	Neutropenia 11/2013 - 05/2011
2	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 11/2013 - 01/2013
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022
1	Neoplasms (Cancer) 01/2022
1	Prostatic Neoplasms (Prostate Cancer) 01/2022
1	Hemophilia A (Haemophilia) 01/2016
1	Chronic Kidney Failure (Chronic Renal Failure) 12/2014
1	Invasive Candidiasis 05/2011
1	Aspergillosis 05/2011
1	Fever (Fevers) 05/2011

Drug/Important Bio-Agent (IBA)

3	DexpramipexoleIBA 12/2014 - 01/2013
1	isatuximabIBA 01/2022
1	cemiplimabIBA 01/2022
1	AntibodiesIBA 01/2022
1	B7-H1 AntigenIBA 01/2022
1	factor VIII-Fc fusion proteinIBA 01/2016

Therapy/Procedure

2	Therapeutics 01/2022 - 05/2011
1	Castration 01/2022
1	Renal Dialysis (Hemodialysis) 12/2014